NSE · Healthcare · Medical Care Facilities
EPS came in at 1.04 against a street estimate of 1.48 — a miss of 29.7%.
with an average price target of ₹869.59.
CONFIDENT KIMS delivered 36% revenue growth to INR 1,196 Cr in Q1 FY27, though PAT fell 57% YoY to INR 37 Cr due to new hospital losses and debt costs. Strong ramp-up at Kondapur and Kerala expansion underway. Q1 FY27 Telangana cluster firing on all cylinders; Bangalore Mahadevapura breakeven achieved but Electronic City still loss-making. Kerala in growth phase, single-digit margins expected through FY27, targeting 20–22% by FY30. Maharashtra lagging due to doctor part-time culture; Nagpur showing inflection. Analysts pressed on occupancy puzzle (52% Telangana), Bangalore ARPOB sustainability (INR 90K inflated), and Thane ramp delay (empanelment resolved by July). Management clarified: Secunderabad renovation and Kondapur beds explain occupancy; case mix inflates Bangalore ARPOB to INR 80–85K fair value; Thane traction visible post-GIPSA empanelment (INR 21 Cr July revenue, 10% margin).…
Full summary in the app.
| Document | Date |
|---|---|
| Q1 FY27 earnings call KIMS HOSPITALS Q1 FY '27 EARNINGS SUMMARY HEADLINE NUMBERS • Total revenue: INR 1,196 crore, up 36.1% year-on-year and 10.3% quarter-on-quarter • Co | 2026-08-08 |
| Annual report FY2026 KIMS HOSPITALS LIMITED – FY 2025-26 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Revenue: ₹39,308 Million for FY 2025-26 • EBITDA Margin: 21.1% • | 2026-08-05 |
| Investor presentation · Q1 FY27 KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED - INVESTOR SUMMARY Q1 FY27 (Quarter Ended 30 June 2026) --- HEADLINE NUMBERS • Total Revenue Q1 FY27: | 2026-08-03 |
| Quarterly results · Q1 FY27 KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED - Q1 FY2027 SUMMARY HEADLINE NUMBERS STANDALONE (Q1 FY2027 ended 30 June 2026): • Revenue from operati | 2026-08-03 |
| Q4 FY26 earnings call KIMS HOSPITALS Q4 FY '26 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Q4 FY '26 Total Revenue: INR 1,084 crore – growth of 35.3% year-on-year, 8. | 2026-05-22 |
| Investor presentation · Q4 FY26 KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED - INVESTOR SUMMARY --- HEADLINE NUMBERS • Total Revenue FY26: ₹39,308 million (₹39.3 billion), up 28. | 2026-05-16 |
| Quarterly results · Q4 FY26 KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED – FINANCIAL RESULTS SUMMARY Year Ended March 31, 2026 --- HEADLINE NUMBERS • Auditor Opinion: Unmodif | 2026-05-15 |
| Q3 FY26 earnings call KIMS HOSPITAL Q3 FY26 EARNINGS SUMMARY HEADLINE NUMBERS • Total Revenue (Consolidated): INR 1,003 crores in Q3 FY26, growth of 2.2% year-on-year and | 2026-02-13 |
Readable in the app.
| Announcement | Date |
|---|---|
| Clarification on potential stake acquisition in Renova Hospitals Krishna Institute of Medical Sciences Limited (KIMS) issued a clarification on August 26, 2026, denying a news report published on dealstreetasia.com claiming the company was in talks to acq | 2026-08-26 |
| Acquisition of another entity completed Krishna Institute of Medical Sciences Limited has informed the Exchange about Acquisition | 2026-02-06 |
| Further acquisition of shares in Sarvejana Healthcare Private Limited Krishna Institute of Medical Sciences Limited (KIMS), a major healthcare company, has announced an additional investment to acquire more shares in Sarvejana Healthcare Private Limited, a sma | 2025-12-19 |
| Amalgamation/Merger transaction announced Krishna Institute of Medical Sciences Limited has informed the Exchange about Amalgamation/Merger | 2025-11-07 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Krishna Institute of Medical Sciences Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.